nach oben

Erschienen in:

01.02.2010 | Original Research

Billing for Medical Genetics and Genetic Counseling Services: A National Survey

verfasst von: Tabitha A. Harrison, Debra Lochner Doyle, Caroline McGowan, Leslie Cohen, Elizabeth Repass, Ruthann B. Pfau, Trish Brown

Erschienen in: Journal of Genetic Counseling | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

In January 2007 the American Medical Association added a new Current Procedural Terminology® (CPT) code, 96040, for “Medical Genetics and Genetic Counseling Services.” In order to identify the impact of having this new code and to identify issues with implementation of the code, the National Society of Genetic Counselors (NSGC) CPT® Working Group surveyed NSGC members using an internet-based survey tool. The majority of respondents (94%) reported being aware of the new code and over half of the respondents (69%) said they were billing for genetic counseling. Approximately 24% of those billing reported using 96040. Many facilities are not using this code and the reported success of billing using 96040 is highly varied. Continued education may be beneficial to encourage reimbursement for 96040 and follow up is needed to assess the ongoing implementation and impact of the new CPT® code.

American College of Medical Genetics. (2002). In M. Williams (Ed.), Manual on reimbursement for medical genetic services. Dubuque: Kendall/Hunt.

American College of Obstetricians and Gynecologists. (2008). Ethical issues in genetic testing. ACOG committee opinion number 410. Obstetrics & Gynecology, 111, 1495–1502.

American Medical Association. (2006). CPT® changes 2007: An insider’s view. Chicago: American Medical Association.

American Society of Human Genetics Board of Directors, & American College of Medical Genetics Board of Directors. (1995). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 57(5), 1233–1241.

Bernhardt, B. A., & Pyeritz, R. E. (1989). The economics of clinical genetics services. III. Cognitive genetics services are not self-supporting. American Journal of Human Genetics, 44(2), 288–293.PubMed

Bernhardt, B. A., & Pyeritz, R. E. (1992). The organization and delivery of clinical genetic services. Pediatric Clinics of North America, 39(1), 1–12.PubMed

Bernhardt, B. A., Weiner, J., Foster, E. C., Tumpsonn, J. E., & Pyeritz, R. E. (1987). The economics of clinical genetics services. II. A time analysis of a medical genetics clinic. American Journal of Human Genetics, 41(4), 559–565.PubMed

Bernhardt, B. A., Peshkin, B. N., & Kemel, Y. (1998). Billing and record-keeping for familial cancer risk counseling: a national survey. Journal of Genetic Counseling, 7, 317–330.CrossRef

Bernhardt, B. A., Biesecker, B. B., & Mastromarino, C. L. (2000). Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment. American Journal of Medical Genetics, 94, 189–197.CrossRefPubMed

Cohn, G. M., Cimaroli, T., Gould, M., Macri, C. J., Habecker-Green, J., & Miller, R. C. (1996). The usefulness of a prenatal genetic questionnaire in genetic risk assessment. Obstetrics and Gynecology, 88, 806–810.CrossRefPubMed

Ciske, D. J., Haavisto, A., Laxova, A., Zeng, L., Rock, M., & Farrell, P. M. (2001). Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics, 107, 699–705.CrossRefPubMed

Frezzo, T. M., Rubinstein, W. S., Dunham, D., & Ormand, K. E. (2003). The genetic family history as a risk assessment tool in internal medicine. Genetics in Medicine, 5(2), 84–91.CrossRefPubMed

Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., et al. (1997). The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. NEJM, 336(12), 823–827.CrossRefPubMed

Hiraki, S., Ormand, K. E., Kim, K., & Ross, L. F. (2006). Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children. American Journal of Medical Genetics, 140(21), 2312–2319.PubMed

Katz, A., & Thompson, J. (1996). The role of public policy in health care market change. Health Affairs, 15(2), 77–92.CrossRefPubMed

Keller, M., Jost, R., Haunstetter, C. M., Sattel, H., Schroeter, C., Bertsch, U., et al. (2008). Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members. Clinical Genetics, 74(5), 414–424.CrossRefPubMed

Khatcheressian, J. L., Wolff, A. C., Smith, T. J., Grunfeld, E., Muss, H. B., Vogel, V. G., et al. (2006). American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. Journal of Clinical Oncology, 24(31), 5091–5097.CrossRefPubMed

McPherson, E., Zaleski, C., Benishek, K., McCarty, C. A., Giampietro, P. F., Reynolds, K., et al. (2008). Clinical genetics provider real-time workflow study. Genetics in Medicine, 10(9), 699–706.CrossRefPubMed

Medical Malpractice: Wrongful birth, preconception torts, duty to inform of genetic risks. (1979). Akron Law Review, 13, 390–400. (Court Cases Park v. Chessin, Becker v. Schwartz, Howard v. Lecher, and Gleitman v. Cosgrove).

Nelson, R. M., Botkjin, J. R., Kodish, E. D., Levetown, M., Truman, J. T., Wilfornd, B. S., et al. (2001). Ethical issues with genetic testing in pediatrics. Pediatrics, 107(6), 1451–1455.CrossRefPubMed

Parrott, S., & Del Vecchio, M. (2007). Professional status survey 2006. Wallingford: National Society of Genetic Counselors, Inc.

Pirzadeh, S. M., McCarthy Veach, P., Bartels, D. M., Kao, J., & LeRoy, B. S. (2007). A national survey of genetic counselors’ personal values. Journal of Genetic Counseling, 16(6), 763–773.CrossRefPubMed

Pyeritz, R. E., Tumpson, J. E., & Bernhardt, B. A. (1987). The economics of clinical genetics services. I. Preview. American Journal of Human Genetics, 41, 549–558.PubMed

Reed, S. (1955). Counseling in medical genetics. Philadelphia: Saunders.

Resta, R. G. (2003). In memoriam: Sheldon Clark Reed, PhD, 1910–2003. Journal of Genetic Counseling, 12, 283–285.CrossRef

StataCorp. (2007). Stata statistical software: Release 10. College Station: StataCorp LP.

U.S. Department of Health and Human Services (2006). Coverage and reimbursement of genetic tests and services: Report of the secretary’s advisory committee on genetics,health, and society, from http://oba.od.nih.gov/oba/sacghs/reports/CR_report.pdf.

Zahm, K. W., McCarthy Veach, P., & LeRoy, B. S. (2008). An investigation of genetic counselor experiences in peer groups supervision. Journal of Genetic Counseling, 17(3), 220–233.CrossRefPubMed

Titel: Billing for Medical Genetics and Genetic Counseling Services: A National Survey
verfasst von: Tabitha A. Harrison
Debra Lochner Doyle
Caroline McGowan
Leslie Cohen
Elizabeth Repass
Ruthann B. Pfau
Trish Brown
Publikationsdatum: 01.02.2010
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 1/2010
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-009-9249-5

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Billing for Medical Genetics and Genetic Counseling Services: A National Survey

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Update Gynäkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Perceptions of High-Risk Care and Barriers to Care Among Women at Risk for Hereditary Breast and Ovarian Cancer following Genetic Counseling in the Community Setting

Primary Care Providers’ Responses to Patient-Generated Family History

Views of Discrimination among Individuals Confronting Genetic Disease

“Stepping Out to Step In”

Explaining Mendelian Inheritance in Genetic Consultations: An IPR Study of Counselor and Counselee Experiences

The Genome Book: A Must-Have Guide to Your DNA for Maximum Health by April Lynch with Vickie Venne MS CGC. Sunrise River Press, North Branch, MN 55056, April 2009, 239 pp., $14.95

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Update Gynäkologie